Publications by authors named "Sue Cheeseman"

Claim this Profile
A
Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records.
Paul Cottu, Sue Cheeseman, Peter Hall, Achim Wöckel, Christian W Scholz

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis.
Eleanor Ralphs, Caroline Rault, Alan Calleja, Melinda J Daumont, John R Penrod, Sue Cheeseman

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Anouchka Seesaghur, Peter Egger, Joshua Warden, Ali Abbasi, Bethany Levick, Sue Cheeseman

BMJ Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes.
Sue Cheeseman, Bethany Levick, Will Sopwith, Hayley Fenton, Eun Ji Nam

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative.
Michael Snee, Sue Cheeseman, Matthew Thompson, Majid Riaz, Will Sopwith

BMJ Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative.
Michael Snee, Sue Cheeseman, Matthew Thompson, Majid Riaz, Will Sopwith

BMJ Open· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre.
Sue Cheeseman, Matthew Thompson, Will Sopwith, Paul Godden, Divyagiri Seshagiri

Front Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre.
Chris Twelves, Sue Cheeseman, Will Sopwith, Matthew Thompson, Majid Riaz

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Angus G Dalgleish, Justin Stebbing, Douglas J A Adamson, Seema Safia Arif, Paolo Bidoli, Sue Cheeseman

Br J Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Angus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, Seema Safia Arif, Paolo Bidoli, Sue Cheeseman

Br J Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis